Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-24-003913
Filing Date
2024-04-11
Accepted
2024-04-11 08:37:37
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 27648
2 filename2.txt TEXT-EXTRACT 1492
  Complete submission text file 0000000000-24-003913.txt   40309
Mailing Address 345 PARK AVENUE SOUTH FLOOR 6 NEW YORK NY 10010
Business Address 345 PARK AVENUE SOUTH FLOOR 6 NEW YORK NY 10010 (212) 547-9879
Lexeo Therapeutics, Inc. (Filed for) CIK: 0001907108 (see all company filings)

EIN.: 854012572 | Fiscal Year End: 1231
Type: UPLOAD | File No.: 333-278566
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)